Depression and Anxiety Trial, Recruiting NCT06928740 Sponsor: Centre Hospitalier Universitaire de Nīmes Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06928740
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have given their free and informed consent and signed the consent form
  • People who are members of or covered by a health insurance plan
  • People who have lower back pain for which a scan-guided injection has been recommended (for example, injections into the spinal openings, back joints, a nerve in the pelvis, the space around the spinal cord, the joint where the spine meets the pelvis, or through a small opening at the base of the spine)
  • People who score 35 or higher out of 100 on an anxiety measurement questionnaire called the STAI-ETAT

Who may not be able to join:

  • People who are currently taking part in another drug trial or a certain type of medical study, or who are within a required waiting period after a previous study
  • People who decline to sign the consent form
  • People for whom it is not possible to provide informed information about the study
  • People who are under legal protection or court-appointed guardianship
  • People for whom an epidural injection specifically has been recommended (confirm with trial site)
  • People who are deaf or hard of hearing
  • People who have a medical reason they cannot receive the intervention called EMONO (confirm with trial site for details)
  • People who have injuries to the face or head that would make it impossible to wear a face mask or headphones

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Florelle TERRA, Centre Hospitalier Universitaire de Nīmes

Phone: 06.37.59.77.34

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire de Nīmes
Registry
ClinicalTrials.gov
Start date
21 October 2025
Est. completion
1 June 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Anxiety between groups; Anxiety between groups; Anxiety between groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov